Rehab Station Stockholm
Stockholm, Solna, 169 89, Sweden
NCT Number: NCT02808000
This is a prospective, cross-over, randomized, controlled, partly blinded study evaluating safety and performance of noble metal alloy urinary Catheters (BIP Foley, Bactiguard AB) of both latex and silicone. The included patients are permanently catheterized spinal cord injured patients at the Spinalis clinic at Rehab station in Stockholm, Sweden.
Primary Outcome Measures:
• The primary objective is to evaluate the efficacy of long term suprapubic use of BIP Foley catheters, compared to the use of standard catheters for the same time period, on re-current symptomatic catheter associated urinary tract infection (CAUTIs).
Secondary Outcome Measures:
• to evaluate safety/performance of the catheter, i.e. antibiotic use, bacteriuria, bacteremia, urosepsis and ICU stay.
Exploratory Outcome Measures:
• assessment of levels of immunological markers in urine, urinary bacterial type and resistance pattern, catheter comfort, stability of the coating, and bacterial biofilm on the catheter surface after use.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Stockholm, Solna, 169 89, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Noble metal coated urinary catheters
Other names: Standard urinary catheter
Time frame: ~4 year observational time, the study has an open end and may be prolonged
The frequency of CAUTI will be recorded and compared between the use of standard urinary catheter and BIP Foley (with noble metal coating)
Time frame: ~4 year observational time, the study has an open end and may be prolonged
To assess and compare the frequency and type of adverse events and catheter related adverse events in the two arms
Time frame: ~4 year observational time, the study has an open end and may be prolonged
The coated and uncoated catheters will be compared with regards to number of easy catheterization.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
To assess and compare any differences of type of antibiotics used for CAUTI in the two arms.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
To assess and compare any differences of antibiotic dose used for CAUTI in the two arms.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
To assess and compare any differences of number of treatment days of antibiotics used for CAUTI in the two arms.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
To asess and compare the spontaneous urinary and blood cultures and CRP blood in the two arms
Time frame: ~4 year observational time, the study has an open end and may be prolonged
To asess and compare the incidence of bacteruria, bacteremia, urosepsis and asymptomatic bacteremiain the two arms
Time frame: ~4 year observational time, the study has an open end and may be prolonged
Urine and blood samples as well as used BIP Foley catheters, will be collected during the study visit, and the samples will be analysed with regards to metal concentrations (Ag, Au, and Pd).
Time frame: ~4 year observational time, the study has an open end and may be prolonged
The outcome of the questionnaire will be compared between the groups (standard versus coated catheter). The questions assess urine smell, appearance of the urine (i.e. colour), discomfort caused by the catheter, catheter blockage, discomfort at insertion/removal, and will be rated in a three-scale (not at all, little, much).
Time frame: ~4 year observational time, the study has an open end and may be prolonged
Urine samples will be collected during the study visit, and will be analysed with regards to inflammatory markers. Inflammatory levels (e.g. cytokines IL-8 and microparticles) will be determined, and compared between the groups.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
The occurancy of bacterial strains in the two groups will be compared in urine samples collected at each study visit.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
The resistance pattern of present urinary bacteria in the two groups will be compared in urine samples collected at each study visit.
Time frame: ~4 year observational time, the study has an open end and may be prolonged
Biofilm amount on the catheter surface of uncoated and coated catheters will be assessed and compared by using SEM. Amounts will be given as % biofilm covering the surface area.
Bactiguard AB
Industry
Evaluation of Suprapubic Noble Metal Alloy BIP Foley Catheter in the Prevention of Catheter-associated Urinary Tract Infections in Spinal Cord Injured Patients
Acronym: CDOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05880602
Disease Attributes, Female Urogenital Diseases
Taichung, Taiwan
View Trial DetailsNCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial DetailsNCT01800799
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Hualien City, Taiwan
View Trial DetailsNCT07702916
Anemia, Female Urogenital Diseases
Antananarivo, Madagascar
View Trial Details